Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
54,053,214
-
Total 13F shares
-
61,083,723
-
Share change
-
+1,715,246
-
Total reported value
-
$412,326,970
-
Put/Call ratio
-
11%
-
Price per share
-
$6.75
-
Number of holders
-
100
-
Value change
-
+$14,153,071
-
Number of buys
-
49
-
Number of sells
-
31
Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q4 2023
As of 31 Dec 2023,
Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,083,723 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, TRV GP IV, LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., and Jefferies Financial Group Inc..
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.